Nina A-Ranberg retweeted
📋 1-year analysis of AID-ICU RCT (n = 1000) reports provocative (or promising?) finding of survival benefit with #haloperidol for ICU #delirium. 🤔
🔗 Link: doi.org/10.1007/s00134-023-0…
📎 Primary (@NEJM) & prior Bayesian analyses here: nitter.gq/MarkOldhamMD/status/16…
🎩/t @carlos_arnaud
Secondary Bayesian analysis of the AID-ICU trial (n = 1000, primary results in @NEJM) finds very high likelihood of benefit & extremely low likelihood of harm with haloperidol for ICU #delirium.
Bayesian analysis: doi.org/10.1007/s00134-023-0…
Primary results: nejm.org/doi/full/10.1056/NE…
Long-term outcomes of the AID-ICU trial now available online👇
@CRIC_Int_Care
@SUHhospital
@MusaeusPoulsen
@ole_mathiesen
@AndersPerner
@andersgranholm
@Innofond
Haloperidol vs placebo in acutely admitted critically ill adults with delirium, follow-up of AID #ICU trial
💉treatment with haloperidol reduces long-term mortality but doesn't appear to improve longterm outcome of health-related quality of life
#FOAMcc
🔓bit.ly/3tEmeiU
Nina A-Ranberg retweeted
Thrombocytopenia in #ICU, PLOT‑ICU study
🩸observed in 43% critically ill adults associated with worse outcomes (½ at admission, with increased mortality)
🩸PLT transfusions frequently used (23%) if severe/very severe thrombocytopenia, most prophylactic
🔓bit.ly/3LQTj0Q
In great company with @timothygirard and @AndersPerner we discuss #AIDICU and #MINDUSA and the current evidence we have for the effects of haloperidol in ICU patients with delirium. Go read👇
💉 Haloperidol & #delirium? Despite new data, uncertainty remains. Is best-studied antipsychotic in #ICU: safe, easy to administer/titrate + better supported by evidence vs others, but do NOT forget to implement nonpharmacologic interventions!
#FOAMcc
🖇️ rdcu.be/dnLXQ
Tomorrow, I will defend my PhD. Everyone is welcome! Should be available online by joining the team-meeting but tech-support is low🍀
Nina A-Ranberg retweeted
Are you an MD or med student interested in evidence-based medicine, clinical trials, or stats/methods?
HELP us assess how different statistical approaches affect clinical trial interpretation here: redcap.link/RE-PRESENT (10-20 min)
Shares & retweets much appreciated!
Are you an MD or med student interested in evidence-based medicine?
Join the RE-PRESENT survey-based trial at redcap.link/RE-PRESENT (10-20 min) to help us learn how different statistical approaches affect clinical trial interpretation.
Responses/shares greatly appreciated!
Nina A-Ranberg retweeted
Haloperidol to treat delirium in the ICU: a meta-analysis
Mortality: 5 RCTs with 1553 pts
Haloperidol🆚placebo
RR 0.89; 96.7% CI 0.77 to 1.03
No significant between-group differences in
- serious adverse events/reactions
- days free from delirium
🔓rdcu.be/dkwAU
Our updated systematic review assessing the effects of haloperidol on mortality and serious adverse events in critically ill patients with delirium is now available online. Data from #AIDICU #EuRIDICE trials are included with existing treatment trials👇
link.springer.com/article/10…
Nina A-Ranberg retweeted
First fluid trial in septic shock patients including longterm outcomes and with only 8.7% missing data, thanks to all collaborators!
💦 Restricting IV fluids in adults with septic shock in #ICU: analysis of CLASSIC trial. Restriction resulted in similar survival, HRQoL, cognitive function at 1 year vs standard therapy but clinically important differences could not be ruled out
#FOAMcc
🖇️rdcu.be/deP7j
Nina A-Ranberg retweeted
Days alive without life support and similar composite outcomes are popular in critical care RCTs.
Here is an updated take on these outcomes led by @andersgranholm!
rdcu.be/deRK9
@AndersPerner @f_g_zampieri @benskov @LangeTheis @marie_warrer @MortenHylander @INCEPTdk
Nina A-Ranberg retweeted
💦 Restricting IV fluids in adults with septic shock in #ICU: analysis of CLASSIC trial. Restriction resulted in similar survival, HRQoL, cognitive function at 1 year vs standard therapy but clinically important differences could not be ruled out
#FOAMcc
🖇️rdcu.be/deP7j
I’m here at @CritCareReviews and looking forward to discuss the results of the AID-ICU trial with colleagues from all over the world today at #CCR23
Visual illustration of the Bayesian analysis of the AID-ICU trial
Haloperidol vs placebo in acutely admitted, adult #ICU pts with #delirium? With IV haloperidol 2.5 mg × 3 daily & as needed doses up to max 20 mg daily
➡️ high probabilities of benefits
➡️ low probabilities of harm
#FOAMcc on @yourICM
🖇️ rdcu.be/dbb8B
⬇️ visual abstract
Nina A-Ranberg retweeted
#TBL 433: AID-ICU - Haloperidol for the Treatment of Delirium
thebottomline.org.uk/summari…
Article by @ARanberg
review by @davidslessor
#FOAMed #FOAMcc
My brother Johan Andersen-Ranberg is improving health from below 🐀👇time.com/6264623/rat-birth-c…
3
284
Nina A-Ranberg retweeted
2/ 🔹 Haloperidol vs. placebo for #delirium treatment 👉 rdcu.be/c8Fqc
🔹 Long-term outcomes of #ICU delirium 👉 rdcu.be/c8Fps
🔹 High-level burnout in physicians and #nurses working in adult #ICU 👉 rdcu.be/c8Fqp
The pre-planned secondary Bayesian analysis of the AID-ICU trial is now available online - this provides a nuanced and probabilistic interpretation of the AID-ICU trial results 👇
Thanks to supervisor @andersgranholm and team @CRIC_Int_Care @AndersPerner @MusaeusPoulsen
Today on World Delirium Awareness Day #WDAD2023 we discuss delirium and haloperidol. Come and join the discussion at 17:00 CET (details 👇 ) @ProfLizSampson @n_jaworska
3
211
Quick overview of the #AIDICU trial with important message in commentary - go read👇:
acpjournals.org/doi/epdf/10.…
Nina A-Ranberg retweeted
100 days to #CCR23
So far
➡️ Results for UK REBOA & DEVICE (video laryngoscopy) trials
➡️ Reviews of TEAM (early mobilisation), PILOT (oxygenation targets), AID-ICU (haloperidol for delirium) & CLOVERS (fluid restriction & early vasopressor in sepsis)
criticalcarereviews.com/meet…
































